Silverback Asset Management’s Medicines Co MDCO Stock Holding History

Silverback Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-50,000	Closed	-$12.9M	–	60
2020 Q1	$12.9M	Sell	50,000 -350,000	-88%	-$29.7M	2.74%	15
2019 Q4	$34M	Buy	+400,000	New	+$26.7M	5.04%	4

Silverback Asset Management's MDCO Position: Q4 2019 in Review

Silverback Asset Management sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 182,500 shares — an estimated $12.2M sold.

Silverback Asset Management first reported a position in MDCO in Q3 2019 and held it in 1 quarter. The position peaked at $9.13K in Q3 2019. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

Silverback Asset Management reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
Silverback Asset Management sold 182,500 Medicines Co shares in Q4 2019, an estimated $12.2M.
Silverback Asset Management first reported a position in Medicines Co in Q3 2019 and held it in 1 quarter.
Silverback Asset Management's Medicines Co position peaked at $9.13K in Q3 2019.
284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Silverback Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.